BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 18227810)

  • 21. Porcine Toll-like receptors: the front line of pathogen monitoring and possible implications for disease resistance.
    Uenishi H; Shinkai H
    Dev Comp Immunol; 2009 Mar; 33(3):353-61. PubMed ID: 18590761
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of innate immune responses in autoimmune disease development.
    Waldner H
    Autoimmun Rev; 2009 Mar; 8(5):400-4. PubMed ID: 19162250
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The interleukin-1 receptor/Toll-like receptor superfamily: 10 years of progress.
    O'Neill LA
    Immunol Rev; 2008 Dec; 226():10-8. PubMed ID: 19161412
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Taking a toll on the bones: regulation of bone metabolism by innate immune regulators.
    Bar-Shavit Z
    Autoimmunity; 2008 Apr; 41(3):195-203. PubMed ID: 18365832
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vascular cell responsiveness to Toll-like receptor ligands in carotid atheroma.
    Erridge C; Burdess A; Jackson AJ; Murray C; Riggio M; Lappin D; Milligan S; Spickett CM; Webb DJ
    Eur J Clin Invest; 2008 Oct; 38(10):713-20. PubMed ID: 18837796
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structures of TLR-ligand complexes.
    Jin MS; Lee JO
    Curr Opin Immunol; 2008 Aug; 20(4):414-9. PubMed ID: 18585456
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nucleic acid-sensing Toll-like receptors: beyond ligand search.
    Miyake K
    Adv Drug Deliv Rev; 2008 Apr; 60(7):782-5. PubMed ID: 18321608
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression and function of Toll-like receptors on dendritic cells and other antigen presenting cells from non-human primates.
    Ketloy C; Engering A; Srichairatanakul U; Limsalakpetch A; Yongvanitchit K; Pichyangkul S; Ruxrungtham K
    Vet Immunol Immunopathol; 2008 Sep; 125(1-2):18-30. PubMed ID: 18571243
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Innate immune sensing and activation of cell surface Toll-like receptors.
    Tapping RI
    Semin Immunol; 2009 Aug; 21(4):175-84. PubMed ID: 19493685
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential expression of Toll-like receptors in chronic hyperplastic candidosis.
    Ali A; Natah S; Konttinen Y
    Oral Microbiol Immunol; 2008 Aug; 23(4):299-307. PubMed ID: 18582329
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic applications of nucleic acids as ligands for Toll-like receptors.
    Panter G; Kuznik A; Jerala R
    Curr Opin Mol Ther; 2009 Apr; 11(2):133-45. PubMed ID: 19330719
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression and function of toll-like receptors at the maternal-fetal interface.
    Koga K; Mor G
    Reprod Sci; 2008 Apr; 15(3):231-42. PubMed ID: 18421019
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toll-like receptors in tonsillar epithelial cells.
    Lange MJ; Lasiter JC; Misfeldt ML
    Int J Pediatr Otorhinolaryngol; 2009 Apr; 73(4):613-21. PubMed ID: 19167100
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Toll-like receptor and RIG-I-like receptor signaling.
    Kawai T; Akira S
    Ann N Y Acad Sci; 2008 Nov; 1143():1-20. PubMed ID: 19076341
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Presymptomatic differences in Toll-like receptor function in infants who have allergy.
    Prescott SL; Noakes P; Chow BW; Breckler L; Thornton CA; Hollams EM; Ali M; van den Biggelaar AH; Tulic MK
    J Allergy Clin Immunol; 2008 Aug; 122(2):391-9, 399.e1-5. PubMed ID: 18571707
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pivotal advance: endogenous pathway to SIRS, sepsis, and related conditions.
    Tang AH; Brunn GJ; Cascalho M; Platt JL
    J Leukoc Biol; 2007 Aug; 82(2):282-5. PubMed ID: 17495051
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Toll-like receptors, transduction-effector pathways, and disease diversity: evidence of an immunobiological paradigm explaining all human illness?
    Atkinson TJ
    Int Rev Immunol; 2008; 27(4):255-81. PubMed ID: 18574739
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The future of toll-like receptor therapeutics.
    Parkinson T
    Curr Opin Mol Ther; 2008 Feb; 10(1):21-31. PubMed ID: 18228178
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunohistochemical localization of Toll-like receptors 1-10 in periodontitis.
    Beklen A; Hukkanen M; Richardson R; Konttinen YT
    Oral Microbiol Immunol; 2008 Oct; 23(5):425-31. PubMed ID: 18793367
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structures of the toll-like receptor family and its ligand complexes.
    Jin MS; Lee JO
    Immunity; 2008 Aug; 29(2):182-91. PubMed ID: 18701082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.